- S. Robert Levine, MD । Founder and CEO, MTM Vision
- Marianne Laouri, PhD, Global Asset Lead, Retinal Health, Boehringer Ingelheim Pharmaceuticals
MTM Vision Fall 2024 Symposium | Announcement: Boehringer Ingelheim and MTM Vision Join Forces to Combat Vision Loss from Diabetes
Latest news
News
Our Meetings
Upcoming: Fall 2025 Symposium
Our fourth annual symposium on “Curing Vision Loss from Diabetes” will bring together a diverse...
Read more 
Personal Experiences
Nicole Johnson
When Nicole Johnson was diagnosed with Type 1 diabetes at 19 years old, she “spiraled into hopelessness”. Flipping pain to ...
Read more
Our Meetings
Spring 2025 Workshop
The Mary Tyler Moore Vision Initiative’s virtual workshop, “Developing Novel Endpoints for Diabetic Retinal Disease Based ...
Read more
Join Our Email List
By submitting this form, you are consenting to receive marketing emails from: Mary Tyler Moore Vision Initiative. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact